Sanofi Faces Contract Suit Over $708M In MS Drug Payments
Sanofi-Aventis US LLC was hit with a breach of contract suit in New York federal court Monday alleging that the pharmaceutical company delayed the development of its multiple sclerosis drug Lemtrada...To view the full article, register now.
Already a subscriber? Click here to view full article